Skip to main content
Fig. 7 | Arthritis Research & Therapy

Fig. 7

From: Quantification of pre-existing radiographic damage and its relationship with joint activity and long-term clinical outcomes with secukinumab therapy in patients with psoriatic arthritis

Fig. 7

SJC in association with erosion score by secukinumab treatment and visits. This analysis is based only on FUTURE 5, since FUTURE 1 deals with unapproved doses. Each panel depicts a scatterplot of joint swollen counts versus erosion scores at three time points (weeks 0, 16, and 52) for each secukinumab dose. The loess smoothed curves depict the overall pattern of SJC and erosion at each time point, and thus the overall improvement in terms of joint counts over time due to secukinumab treatment. Unlike tender joint counts, swollen counts for patients with high radiographical erosion scores do tend to reach more complete remission. MDA, minimal disease activity; N, total number of patients; SJC, swollen joint count; NL, no loading doses

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us